Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52

pharmaphorum

SEPTEMBER 29, 2022

A digital patient monitoring tool developed by UK company CyberLiver has been given a breakthrough designation by the FDA for out-of-hospital management of patients with cirrhosis at risk of complications. The post Digital tool cuts hospital readmissions in cirrhosis patients appeared first on.

Patients 52

Patients Management Consulting FDA 52

pharmaphorum

DECEMBER 14, 2022

When patients experience intense emotion, either positive or negative, they are rendered unconscious. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. One more hurdle to clear.

Competition 116

Competition FDA Pharmaceutical Marketing 116

PM360

SEPTEMBER 21, 2023

This article covers some of the reasons these drugs were chosen, how the process for price negotiation will occur, and the impact for the industry and for patients. Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. billion in 2025. But it is not a simple answer. from 2021 and reach $4.2

Prescription 105

Prescription Medical Patients Side effects 105

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

PM360

OCTOBER 25, 2023

According to a report by McKinsey & Company, the medical affairs function is on track to rise in importance, becoming the third strategic pillar alongside the research and development (R&D) and commercial functions by 2025. Regulatory concerns. A slip here can result in legal issues and harm the company’s reputation.

Management 105

Management Medical Pharma Pharmaceutical 105

Nixon Gwilt Law

JULY 18, 2024

Last week, the Centers for Medicare & Medicaid Services (CMS) released the 2025 Medicare Physician Fee Schedule Proposed Rule (the Proposed Rule). The new APCM codes are stratified into three levels based on patient risk. In alignment with the U.S.

Management 52

Management Physicians Patients Medicine 52

PM360

OCTOBER 8, 2024

Developed to address ongoing provider burnout head-on, the new practice engagement solution reimagines how clinical care teams communicate and collaborate by providing a centralized hub for physicians and staff. PatientPoint plans to release the solution to other specialties within its network in 2025.For

Healthcare Provider 52

Healthcare Provider Pharma reps Pharma Rep Physicians 52

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Prescription refills can now be placed with a simple click on a patient portal. Reconsider the Role of Packaging.

Retail 97

Retail Marketing Healthcare Healthcare 97

Clarify Health

NOVEMBER 21, 2024

According to research from PwC, medical costs alone are projected to rise 7–8% in 2025 , marking the highest increase in over 13 years. By simplifying their technology landscape, health systems can significantly optimize costs, reduce provider burnout, and enhance patient care. Following record healthcare spending of $4.5

Healthcare 52

Healthcare Healthcare Leads Medical 52

pharmaphorum

OCTOBER 10, 2022

However, the global lockdown forced many Americans to utilise telehealth, with many patients, doctors, and hospitals realising the benefits after using it first-hand—and almost 88% of Americans want it to stay for non-urgent appointments. Customer demands encouraged new partnerships among healthcare providers and technology companies.

Food 111

Food Marketing Healthcare Healthcare 111

Pharmacy Times

OCTOBER 1, 2024

Approximately 75% of adults trust their physicians, nurses, and pharmacists either a great deal or a lot, highlighting the importance of pharmacists for patient education.

Physicians 22

Physicians Education Patients 22

Impetus Digital

APRIL 24, 2023

A Vision for Medical Affairs In A Vision for Medical Affairs in 2025 –a recent McKinsey & Company report–the authors provided thought-provoking insights into the evolution of MA, mirroring what we have been hearing first-hand. This offers new opportunities to engage with stakeholders beyond just physicians.

Medical 52

Medical Education Physicians Healthcare 52

PM360

JUNE 16, 2023

The Role of the COVID-19 Pandemic on the Diagnostics Market Landscape Diagnostic testing has always been seen as a valuable tool for healthcare providers (HCPs) to accurately diagnose illness and ensure that patients receive necessary medical care. 2 Patients are the ones reaping the benefits of peace of mind—and early diagnosis.

Marketing 52

Marketing Healthcare Healthcare Medical 52

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. By 2025, several new gene and cell therapies will be coming to market.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Eversana Intouch

SEPTEMBER 27, 2024

Here are a few of the things we learned and some associated implications heading into 2025. Both manufacturers and marketers need to understand how HCPs make these decisions and which patients are likely to benefit from one type of treatment over another. EVERSANA was there with teams from across the U.S.

Patients 59

Patients Medical Healthcare Healthcare 59

European Pharmaceutical Review

DECEMBER 19, 2023

A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient. About 800 million humans are injected with vaccines every year” Most vaccines in use today are relatively cheap to make and are injected into patients with mass‑produced and inexpensive (five-cent) disposable syringes.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111

Clarivate

AUGUST 27, 2024

Increased appeal for dual-energy systems: Sometimes a situation calls for RF, but physicians like the ease and efficiency of PFA. In addition, the improved safety profile of PFA is making the cost-benefit of ablation an easier calculation for many patients. The drop will likely be slower than in cryo, however.

Marketing 52

Marketing Competition FDA Electronics 52

Healthcare Success

DECEMBER 16, 2024

We are not patient facing. Post-acute care, that's where patients go when they are discharged to typically from a hospital. And so, funny enough, we just had our planning meeting to stand up our campaigns for the first half of 2025, and we have a really nice, very simple template of you know. So, I had been on the payer side.

Marketing 52

Marketing Physicians Sales Healthcare 52

Clarivate

OCTOBER 10, 2022

Clarivate oncology experts share key takeaways from the 2022 ESMO Congress and their expected impact on the drug treatment landscape and patients. Positive outcomes in a key patient segment could broaden TRODELVY’s uptake in metastatic breast cancer. Market impact.

Marketing 52

Marketing Safety Patients Competition 52

Contrarian Sales Techniques

FEBRUARY 25, 2023

The film documents the efforts of activists, doctors, and patients to overcome these barriers and increase access to affordable treatment. The film features interviews with activists, physicians, and other experts who discuss the challenges and injustices that arose from the AIDS epidemic and the global response.

Marketing 52

Marketing Distribution Medical Government 52

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. What’s more, tying specific ad campaigns to patient outcomes with traditional TV advertising can be challenging. Best-in-class healthcare marketers are already planning for next year.

Marketing 52

Marketing Media Healthcare Healthcare 52

Evolve Your Success

NOVEMBER 28, 2023

Using innovative AI-assisted devices redefines treatment approaches and envisions a future where technology greatly enhances patient care. Join us as Charles explores the game-changing HiDO device , a groundbreaking technology designed to transform patient care and medication management. Let’s break that down a little bit.

Medical 52

Medical Medical sales Sales Patients 52

Nixon Gwilt Law

JULY 15, 2022

In the Spring of 2022, the Centers for Medicare and Medicaid Services (“CMS”) released its 2022 Behavioral Health Strategy (the “BH Strategy”) to increase access to care and improve patient outcomes. Patient consent for GBHI1 is independently required when it is provided concurrently with other care management services.

Physicians 52

Physicians Management Patients Electronics 52

Nixon Gwilt Law

NOVEMBER 14, 2024

In a significant move to incentivize enhanced primary care delivery and management, the Centers for Medicare & Medicaid Services (CMS) have finalized the Advanced Primary Care Management (APCM) codes in the 2025 Medicare Physician Fee Schedule (the” 2025 Final MPFS” or the “Final Rule”).

Physicians 52

Physicians Management Healthcare Healthcare 52

Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. 1, 2024, following an IRA provision capping patients’ out-of-pocket costs at $35 per month. Although the initial set of drugs included for negotiations was limited to ten, the scope of this program will expand over time.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. This would include drugs covered by both Medicare Part B (physician-administered drugs) and Part D (prescription medications).

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

Clarivate

DECEMBER 14, 2023

However, the PBM-focused strategy can result in higher out-of-pocket costs for patients who pay coinsurance for drugs based on WAC prices and may spur further criticism. Payers will continue to take ownership of providers, with numerous Blue plans staking a claim to settings where they can funnel patients to lower-cost care.

Marketing 52

Marketing Healthcare Healthcare Insurance 52

Clarivate

OCTOBER 17, 2024

The Inflation Reduction Act instead allows the Centers for Medicare & Medicaid Services to begin negotiating Fair Maximum Prices for a growing list of Part D (outpatient) and Part B (physician-administered) drugs that represent the greatest cost to the federal government. Extending them would require Congressional action.

Healthcare 52

Healthcare Healthcare Government Insurance 52